What is AptaPharma?
AptaPharma operates from Pennsauken, NJ, specializing in the intricate development and manufacturing of complex oral and liquid pharmaceutical formulations. The company provides a comprehensive suite of services, encompassing research and development through to commercial-scale production. Leveraging its proprietary SLP technology, AptaPharma aims to serve pharmaceutical entities in need of advanced formulation solutions, ensuring adherence to stringent cGMP compliance across all operational facets.
How much funding has AptaPharma raised?
AptaPharma has raised a total of $509K across 2 funding rounds:
Debt
$150K
Debt
$359K
Debt (2020): $150K with participation from PPP
Debt (2021): $359K led by PPP
What's next for AptaPharma?
The substantial enterprise-level funding indicates AptaPharma is poised for significant expansion, likely focusing on scaling its manufacturing capabilities and potentially broadening its service offerings. This strategic backing suggests a move towards solidifying its market position as a key CDMO for complex pharmaceutical products, enabling further innovation in drug formulation and delivery.
See full AptaPharma company page